viral
discoveri
rapidli
advanc
driven
advent
highthroughput
technolog
like
nextgener
sequenc
ng
appli
ng
diagnost
tool
hold
promis
vastli
expand
understand
spectrum
microb
infect
human
requir
priori
knowledg
pathogen
present
also
potenti
elucid
spectrum
diseasecaus
virus
patient
undiagnos
acut
febril
ill
uafi
common
occurr
health
clinic
around
world
ng
also
serv
increas
power
surveil
system
detect
infrequ
zoonot
transmiss
potenti
becom
pandem
ng
alreadi
use
success
diagnost
tool
mean
discov
novel
virus
associ
human
diseas
exampl
discoveri
includ
novel
arenavirus
phlebovirus
coronavirus
recent
novel
rhabdoviru
refer
bascongo
viru
basv
identifi
blood
patient
central
africa
suspect
suffer
viral
hemorrhag
fever
howev
better
understand
spectrum
virus
infect
human
need
fulli
realiz
potenti
ng
differenti
pathogen
nonpathogen
virus
global
problem
particularli
acut
tropic
region
throughout
world
burden
infecti
diseas
remain
high
bloodstream
virom
larg
number
appar
healthi
individu
character
studi
uafi
lack
comparison
appar
healthi
individu
reli
smallscal
associ
case
even
singl
patient
sampl
without
statist
support
abil
determin
causal
studi
use
highthroughput
ng
elucid
spectrum
rna
virus
present
blood
patient
uafi
popul
southeastern
nigeria
use
appar
healthi
member
commun
comparison
detect
known
common
viral
nucleic
acid
sequenc
uafi
patient
abl
assembl
fulllength
genom
two
novel
highli
diverg
rhabdovirus
two
appar
healthi
individu
found
virus
similar
basv
virus
genu
tibroviru
conduct
serosurvey
studi
cohort
found
exposur
novel
virus
unexpectedli
high
find
suggest
human
infect
certain
type
rhabdovirus
may
common
highlight
need
broader
understand
human
virom
use
ng
microbi
discoveri
advanc
studi
popul
consist
men
women
age
group
socioeconom
background
live
around
irrua
modests
periurban
villag
southeastern
nigeria
descript
studi
popul
see
tabl
part
partnership
irrua
specialist
teach
hospit
isth
studi
lassa
fever
collect
blood
sampl
suspect
lassa
fever
patient
test
neg
lassa
viru
revers
transcript
pcr
rtpcr
subject
ng
tabl
hypothes
uafi
patient
symptom
resembl
viral
hemorrhag
fever
could
infect
pathogen
caus
sever
ill
addit
collect
sampl
appar
healthi
individu
ie
individu
whose
temperatur
normal
rang
overt
symptom
ill
surround
popul
part
genom
project
part
control
popul
studi
lassa
fever
perform
collect
febril
case
appar
healthi
control
approv
irb
protocol
nigeria
oyo
state
ministri
health
isth
us
tulan
univers
harvard
univers
harvard
school
pubic
health
broad
institut
adult
subject
provid
inform
consent
parent
guardian
child
particip
age
year
provid
inform
consent
behalf
children
older
addit
provid
assent
individu
provid
written
inform
consent
individu
unabl
read
studi
staff
read
document
particip
guardian
individu
provid
thumbprint
consent
form
cosign
studi
staff
well
wit
use
thumbprint
specif
approv
irb
grant
institut
collect
approxim
ml
venou
blood
edta
vacutain
tube
centrifug
obtain
plasma
cellular
fraction
inactiv
plasma
ad
buffer
avl
qiagen
ad
carrier
rna
sampl
indic
tabl
case
appar
healthi
control
collect
addit
aliquot
unadulter
plasma
inactiv
buffer
avl
construct
rnaseq
librari
previous
describ
prepar
librari
extract
rna
either
singl
individu
refer
singleton
rna
pool
sever
individu
refer
pool
tabl
treat
sampl
dnase
prime
rna
use
random
hexam
modifi
hexam
integr
dna
technolog
carrier
rna
present
sampl
amplifi
result
librari
pcr
pool
sequenc
illumina
hiseq
accord
manufactur
specif
primer
use
sanger
sequenc
list
tabl
raw
data
deposit
sra
bioproject
id
process
individu
afebril
control
describ
uafi
sampl
howev
method
pool
differ
pool
filter
unadulter
plasma
without
avl
sampl
centrifug
x
g
hour
resuspend
viral
pellet
buffer
use
construct
librari
sequenc
avl
denatur
viral
particl
thu
prevent
centrifug
particl
observ
compar
result
sampl
inactiv
avl
trim
raw
illumina
sequenc
consist
bp
pairedend
read
remov
base
end
read
low
qualiti
score
discard
read
shorter
bp
qualiti
trim
remov
human
contamin
read
use
bmtagger
ncbi
remov
duplic
read
low
complex
read
use
prinseq
assembl
read
de
novo
use
metavelvet
follow
triniti
use
contig
least
bp
blastn
blastx
queri
genbank
nucleotid
nt
protein
nr
databas
escor
cutoff
respect
parallel
pipelin
use
individu
read
blastn
blastx
queri
genbank
escor
cutoff
valu
perform
taxonom
classif
assembl
contig
individu
read
visual
use
megan
consid
sampl
viru
present
megan
min
support
min
score
assess
statist
signific
differ
distribut
virus
uafi
sampl
appar
healthi
individu
use
twotail
fisher
exact
test
consid
signific
use
quantit
realtim
pcr
measur
number
ekpoma
viral
rna
copi
per
millilit
blood
use
rnatoct
kit
appli
biosystem
primer
amplifi
region
polymeras
l
gene
follow
sequenc
forward
revers
primer
forward
revers
amplifi
pcr
reaction
abi
sequenc
detect
system
use
follow
cycl
paramet
minut
minut
cycl
second
minut
serial
dilut
synthet
dna
amplicon
correspond
amplifi
region
polymeras
gene
use
quantifi
number
viral
cdna
copi
reaction
human
rna
rna
purifi
plasma
afebril
individu
use
neg
control
perform
multipl
sequenc
align
rhabdoviru
nucleoprotein
n
glycoprotein
g
matrix
phospoprotein
p
polymeras
l
amino
acid
sequenc
use
mafft
follow
paramet
trim
use
trimal
maximum
likelihood
specif
paramet
use
prottest
identifi
rtrevig
best
evolutionari
model
made
maximum
likelihood
phylogeni
raxml
tree
bootstrap
use
pseudorepl
also
creat
tree
use
mrbay
first
built
tree
use
rhabdoviru
sequenc
includ
parainfluenza
outgroup
find
novirhabdovirus
like
root
rhabdoviru
tree
previous
describ
exclud
parainfluenza
built
tree
use
rhabdoviru
sequenc
fig
allow
us
select
vsv
like
outgroup
tibrovirus
ephemerovirus
subsequ
align
tree
creat
use
tibrovirus
ephemerovirus
includ
basv
well
vsv
found
use
parainfluenza
novirhabdovirus
root
gave
tree
topolog
relev
access
number
found
tabl
clone
histag
n
gene
express
e
coli
lyse
cell
presenc
proteas
inhibitor
purifi
protein
hispur
ninta
spin
column
thermo
scientif
confirm
puriti
protein
western
blot
creat
elisa
plate
coat
n
protein
onto
plate
carbonatebicarbon
buffer
overnight
human
igg
specif
detect
elisa
previous
describ
calcul
cutoff
valu
base
mean
us
control
n
plu
three
five
standard
deviat
select
blood
sampl
uafi
afebril
control
rna
sequenc
illumina
ng
fig
collect
number
demograph
clinic
paramet
tabl
individu
studi
success
construct
rnaseq
librari
uafi
sampl
singleton
pool
compris
total
individu
rnaseq
librari
afebril
appar
healthi
control
sampl
singleton
pool
compris
total
individu
tabl
illumina
sequenc
gener
total
billion
base
pair
bp
pairedend
read
analyz
sampl
use
bioinformat
comput
pipelin
develop
laboratori
fig
filter
lowqual
sequenc
duplic
human
read
common
contamin
less
read
typic
remain
librari
fig
examin
overal
composit
read
identifi
singleton
uafi
sampl
appar
healthi
singleton
control
fig
found
filter
read
return
blast
hit
unabl
unequivoc
assign
eukarotya
prokaryota
viral
kingdom
major
filter
read
uafi
afebril
librari
bacteri
overal
percentag
viral
read
similar
uafi
patient
afebril
control
respect
major
viral
read
deriv
three
sourc
human
adenoviru
c
phage
gb
viru
c
tabl
text
gb
viru
c
nonpathogen
rna
viru
identifi
uafi
singleton
librari
singleton
healthi
control
fig
fig
higher
percentag
pool
healthi
control
contain
gb
viru
c
possibl
pool
contain
greater
number
individu
sampl
compar
uafi
pool
identifi
sever
wellcharacter
pathogen
rna
virus
includ
lasv
hepat
c
dengu
viru
uafi
patient
fig
tabl
find
evid
presenc
ebola
viru
lasv
frequent
pathogen
viru
observ
uafi
case
viru
statist
enrich
uafi
compar
appar
healthi
control
pvalu
fisher
test
fig
although
sampl
dnase
treat
also
detect
sever
dna
virus
includ
hepat
b
viru
herpesviru
epsteinbarr
viru
herpesviru
human
cytomegaloviru
herpesviru
kaposi
sarcoma
viru
fig
tabl
two
pool
rna
afebril
individu
identifi
read
distant
relationship
previous
identifi
rhabdovirus
pcr
assay
develop
identifi
infect
individu
within
pool
reveal
two
infect
femal
age
sampl
sampl
name
two
virus
ekpoma
ekpoma
individu
live
ekpoma
villag
locat
ten
kilomet
isth
assembl
sever
long
contigu
overlap
rhabdoviru
sequenc
contig
fig
contig
synthes
virusspecif
primer
use
sanger
sequenc
confirm
result
illumina
sequenc
fill
miss
part
genom
fig
combin
sequenc
produc
two
genom
bp
bp
genbank
access
number
coverag
rang
median
coverag
rang
median
fig
find
addit
sampl
contain
read
two
novel
rhabdovirus
rhabdovirida
famili
includ
least
eleven
genera
found
genom
organ
like
basv
member
genu
tibroviru
fig
viral
genom
consist
prototyp
five
open
read
frame
orf
found
rhabdovirus
n
p
g
l
well
least
three
addit
orf
unknown
function
fig
latter
three
orf
also
seen
member
genu
tibroviru
presenc
clearli
distinguish
virus
close
relat
genu
ephemeroviru
found
sequenc
ident
among
ekpoma
virus
low
rang
differ
orf
protein
level
fig
nucleoprotein
polymeras
highli
conserv
protein
fig
diverg
overal
similar
amino
acid
level
basv
ident
ident
determin
place
ekpoma
virus
within
rhabdoviru
phylogeni
construct
maximum
likelihood
bayesian
tree
major
viral
protein
found
cluster
basv
tibv
coastal
plain
viru
fig
found
closer
evolutionari
rel
tibv
basv
contrast
form
anoth
branch
basv
fig
b
though
virus
discov
geograph
distant
locat
phylogenet
analys
suggest
presenc
distinct
group
virus
tibroviru
genu
capabl
human
infect
base
phylogenet
relationship
host
rang
genom
architectur
propos
basv
includ
within
genu
tibroviru
assess
level
human
exposur
novel
rhabdovirus
develop
enzymelink
immunosorb
assay
elisa
detect
antibodi
recogn
n
protein
perform
serosurvey
sampl
found
significantli
nigerian
individu
n
antibodi
appar
healthi
us
control
n
fig
pvalu
mannwhitney
test
use
conserv
posit
cutoff
valu
found
nigerian
individu
show
evid
previou
exposur
tabl
fig
seroposit
much
higher
nigerian
show
evid
previou
exposur
tabl
fig
observ
signific
differ
sex
agerang
individu
antibodi
titer
fig
rule
assay
crossreact
similar
rhabdovirus
could
inflat
overal
seropreval
observ
ekpoma
virus
howev
note
limit
crossreact
observ
fig
found
strong
crossreact
assay
rabi
viru
fig
correl
rabi
viru
much
less
pronounc
fig
importantli
test
gener
crossreact
assay
compar
elisa
result
rhabdovirus
lasv
find
correl
fig
acut
infect
rna
virus
often
produc
high
viral
load
assess
level
viremia
use
quantit
realtim
pcr
measur
viral
copi
number
detect
million
viral
genom
copi
per
millilit
plasma
individu
infect
viral
genom
copi
per
millilit
plasma
individu
infect
fig
number
inform
interpret
caution
sampl
degrad
may
affect
number
viral
copi
detect
discoveri
two
ekpoma
virus
sought
determin
health
infect
individu
nearli
two
year
initi
blood
draw
conduct
oral
interview
individu
collect
convalesc
serum
sampl
individu
test
neg
two
ekpoma
virus
pcr
upon
test
convalesc
sampl
fig
howev
use
elisa
assay
found
antibodi
react
expect
fig
notabl
individu
antibodi
titer
time
infect
followup
sampl
woman
infect
show
lower
titer
followup
sampl
compar
origin
blood
draw
fig
woman
infect
could
recal
episod
febril
ill
week
month
follow
collect
initi
blood
sampl
woman
infect
reveal
suffer
episod
febril
ill
two
week
collect
blood
sampl
admit
hospit
ill
clinic
diagnos
malaria
individu
ill
resolv
antimalari
treatment
confirm
whether
malaria
parasit
causal
agent
attempt
isol
use
plasma
infect
individu
inocul
cultur
vero
bhk
mosquito
bite
midg
culicoid
variipenni
cell
line
observ
evid
viral
cytopath
effect
cultur
could
detect
viru
qpcr
electron
microscopi
also
attempt
isol
virus
intracrani
inocul
newborn
mice
howev
observ
sign
ill
day
possibl
virus
may
abl
infect
test
cell
anim
howev
potenti
sampl
degrad
may
compromis
infect
viral
particl
use
highthroughput
ng
elucid
spectrum
rna
virus
present
blood
patient
uafi
popul
southeastern
nigeria
use
appar
healthi
member
commun
comparison
ng
advantag
abl
identifi
pathogen
without
cultur
priori
knowledg
pathogen
nucleic
acid
sequenc
despit
advantag
ng
certain
bias
approach
first
select
blood
limit
investig
singl
anatom
compart
mani
virus
detect
blood
eg
rabi
viru
strictli
neurotrop
complet
understand
febril
healthi
person
virom
necessit
sequenc
tissu
bodi
practic
reason
possibl
abil
identifi
novel
virus
also
limit
sequenc
homolog
exist
sequenc
public
databas
highli
diverg
truli
novel
pathogen
may
miss
convent
blast
search
studi
filter
read
return
blast
hit
unabl
unequivoc
assign
eukaryotya
prokaryota
viral
kingdom
despit
limit
howev
abl
identifi
amino
acid
similar
alreadi
known
virus
studi
made
unexpect
discoveri
nucleic
acid
sequenc
suggest
novel
rhabdovirus
appar
healthi
control
identifi
virus
close
resembl
member
genu
tibroviru
particular
basv
base
genom
structur
phylogen
analys
basv
recent
identifi
individu
central
africa
display
symptom
suggest
viral
hemorrhag
fever
despit
detect
appar
healthi
individu
close
relat
viru
basv
identifi
date
tibrovirus
includ
tibrogargan
coastal
plain
biven
arm
virus
transmit
culicoidi
insect
known
caus
subclin
infect
cattl
rumin
amino
acid
sequenc
similar
tibrogargan
coastal
plain
virus
rais
possibl
might
vectorborn
true
infect
could
common
environ
bite
insect
ubiquit
like
central
western
africa
mani
rhabdovirus
alreadi
discov
subsaharan
africa
use
convent
insect
vertebr
fig
result
suggest
mani
remain
discov
number
may
infect
human
consist
potenti
widespread
subclin
infect
rhabdovirus
serosurvey
uncov
evid
high
exposur
nearli
appar
healthi
cohort
show
evid
exposur
despit
high
rate
detect
nucleic
acid
uafi
patient
result
suggest
member
genu
tibroviru
unlik
common
caus
viral
hemorrhag
fever
suggest
basv
attempt
isol
unsuccess
effort
specul
sampl
handl
may
caus
degrad
viral
particl
altern
novel
virus
may
infect
common
cell
type
select
cultur
histor
isol
viru
infect
individu
necessari
step
demonstr
exist
novel
viru
patient
infect
howev
ng
becom
common
like
mani
new
virus
identifi
easili
cultur
mean
virus
studi
biochem
recreat
laboratori
part
viru
synthes
de
novo
incorpor
exist
viral
vector
case
entir
nucleic
acid
sequenc
viru
synthes
de
novo
introduc
cell
potenti
cultur
recent
discoveri
three
relat
appar
healthi
individu
studi
one
acut
ill
patient
challeng
determin
true
caus
unexplain
ill
mani
factor
determin
whether
particular
viru
produc
diseas
infect
host
includ
genet
variat
viru
host
nutrit
immun
statu
presenc
coinfect
may
increas
suscept
otherwis
benign
agent
identifi
caus
diseas
becom
even
challeng
sinc
multipl
microb
present
sampl
includ
commens
bacteria
virus
prove
diseas
causal
centuriesold
problem
identifi
potenti
pathogen
mere
first
step
long
process
research
recent
propos
revis
koch
first
framework
assess
light
advanc
modern
molecular
techniqu
add
rigor
pursuit
yet
still
number
limit
current
studi
mani
studi
investig
abl
studi
singl
patient
sampl
without
suffici
number
sampl
infect
patient
match
appar
healthi
individu
imposs
interpret
clinic
signific
singl
viru
detect
remain
possibl
basv
produc
asymptomat
infect
like
control
subject
infect
studi
acut
ill
actual
due
anoth
agent
like
rotaviru
author
propos
laboratori
contamin
one
mani
bacteria
also
present
sampl
cours
true
sourc
infect
could
none
microb
identifi
blood
sampl
tissu
would
need
rule
local
infect
caus
diseas
regardless
whether
infect
particular
rhabdovirus
symptomat
discoveri
novel
rhabdovirus
could
import
human
health
member
rhabdovirida
lyssavirus
vesiculovirus
produc
seriou
neurotrop
diseas
human
other
vesicular
stomat
viru
vsv
produc
subtl
neurotrop
infect
acut
diseas
symptom
basv
like
vsv
appear
broad
tissu
tropism
may
infect
similar
cell
type
studi
need
determin
novel
rhabdovirus
discov
studi
produc
neurotrop
outcom
human
similar
lyssavirus
vesiculovirus
futur
studi
use
ng
tackl
issu
diseas
causal
newli
discov
microb
obviou
approach
involv
find
statist
associ
microb
diseas
nondiseas
state
similarli
show
lasv
studi
fig
requir
collect
match
control
either
patient
member
commun
diseas
approach
face
challeng
viral
host
factor
play
substanti
role
diseas
outcom
might
necessit
larg
sampl
collect
isol
pathogen
propag
anim
model
tissu
cultur
provid
valuabl
insight
pathogen
effect
host
respons
infect
recent
advent
ng
potenti
transform
centuriesold
pursuit
find
diseasecaus
pathogen
elucid
complet
human
virom
process
import
cautiou
vast
major
virus
studi
past
centuri
caus
diseas
largescal
sequenc
sampl
vertebr
insect
like
bias
toward
identifi
novel
benign
virus
rather
pathogen
one
although
mani
newli
discov
virus
may
caus
overt
symptom
diseas
may
immunolog
development
increas
suscept
pathogen
affect
aspect
human
develop
pathogen
discoveri
tool
evolv
rapidli
investig
har
new
tool
like
identifi
plethora
new
virus
human
anim
insect
develop
system
assess
causal
especi
thorough
sampl
nondiseaseaffect
control
critic
realiz
potenti
ng
routin
diagnost
tool
